192 related articles for article (PubMed ID: 24819505)
1. Regulation and novel action of thymidine phosphorylase in non-small cell lung cancer: crosstalk with Nrf2 and HO-1.
Tertil M; Skrzypek K; Florczyk U; Weglarczyk K; Was H; Collet G; Guichard A; Gil T; Kuzdzal J; Jozkowicz A; Kieda C; Pichon C; Dulak J
PLoS One; 2014; 9(5):e97070. PubMed ID: 24819505
[TBL] [Abstract][Full Text] [Related]
2. Nrf2-heme oxygenase-1 axis in mucoepidermoid carcinoma of the lung: Antitumoral effects associated with down-regulation of matrix metalloproteinases.
Tertil M; Golda S; Skrzypek K; Florczyk U; Weglarczyk K; Kotlinowski J; Maleszewska M; Czauderna S; Pichon C; Kieda C; Jozkowicz A; Dulak J
Free Radic Biol Med; 2015 Dec; 89():147-57. PubMed ID: 26393425
[TBL] [Abstract][Full Text] [Related]
3. Thymidine kinase 1 and thymidine phosphorylase expression in non-small-cell lung carcinoma in relation to angiogenesis and proliferation.
Brockenbrough JS; Morihara JK; Hawes SE; Stern JE; Rasey JS; Wiens LW; Feng Q; Vesselle H
J Histochem Cytochem; 2009 Nov; 57(11):1087-97. PubMed ID: 19654105
[TBL] [Abstract][Full Text] [Related]
4. Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis.
Skrzypek K; Tertil M; Golda S; Ciesla M; Weglarczyk K; Collet G; Guichard A; Kozakowska M; Boczkowski J; Was H; Gil T; Kuzdzal J; Muchova L; Vitek L; Loboda A; Jozkowicz A; Kieda C; Dulak J
Antioxid Redox Signal; 2013 Sep; 19(7):644-60. PubMed ID: 23617628
[TBL] [Abstract][Full Text] [Related]
5. Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival.
Koukourakis MI; Giatromanolaki A; Kakolyris S; O'Byrne KJ; Apostolikas N; Skarlatos J; Gatter KC; Harris AL
Br J Cancer; 1998 May; 77(10):1696-703. PubMed ID: 9635852
[TBL] [Abstract][Full Text] [Related]
6. Metformin Sensitizes Non-small Cell Lung Cancer Cells to an Epigallocatechin-3-Gallate (EGCG) Treatment by Suppressing the Nrf2/HO-1 Signaling Pathway.
Yu C; Jiao Y; Xue J; Zhang Q; Yang H; Xing L; Chen G; Wu J; Zhang S; Zhu W; Cao J
Int J Biol Sci; 2017; 13(12):1560-1569. PubMed ID: 29230104
[TBL] [Abstract][Full Text] [Related]
7. Thymidine phosphorylase and vascular endothelial growth factor in patients with Stage I lung adenocarcinoma.
Kojima H; Shijubo N; Abe S
Cancer; 2002 Feb; 94(4):1083-93. PubMed ID: 11920479
[TBL] [Abstract][Full Text] [Related]
8. bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer.
Koukourakis MI; Giatromanolaki A; O'Byrne KJ; Cox J; Krammer B; Gatter KC; Harris AL
Clin Exp Metastasis; 1999; 17(7):545-54. PubMed ID: 10845553
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived endothelial cell growth factor/thymidine phosphorylase concentrations differ in small cell and non-small cell lung cancer.
Yamashita J; Ogawa M; Abe M; Nishida M
Chest; 1999 Jul; 116(1):206-11. PubMed ID: 10424527
[TBL] [Abstract][Full Text] [Related]
10. Thymidine phosphorylase influences [(18)F]fluorothymidine uptake in cancer cells and patients with non-small cell lung cancer.
Lee SJ; Yeo JS; Lee HJ; Lee EJ; Kim SY; Jang SJ; Lee JJ; Ryu JS; Moon DH
Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1327-35. PubMed ID: 24562648
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of MUC1 enhances proangiogenic activity of non-small-cell lung cancer cells through activation of Akt and extracellular signal-regulated kinase pathways.
Yao M; Zhang W; Zhang Q; Xing L; Xu A; Liu Q; Cui B
Lung; 2011 Dec; 189(6):453-60. PubMed ID: 21959954
[TBL] [Abstract][Full Text] [Related]
12. Focal expression of thymidine phosphorylase associates with CD31 positive lymphocytic aggregation and local neo-angiogenesis in non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Kakolyris S; Kaklamanis L; Barbatis K; O'Byrne KJ; Theodosssiou D; Harris AL; Gatter KC
Anticancer Res; 1998; 18(1A):71-6. PubMed ID: 9568058
[TBL] [Abstract][Full Text] [Related]
13. Thymidine phosphorylase enhances reactive oxygen species generation and interleukin-8 expression in human cancer cells.
Tabata S; Ikeda R; Yamamoto M; Furukawa T; Kuramoto T; Takeda Y; Yamada K; Haraguchi M; Nishioka Y; Sone S; Akiyama S
Oncol Rep; 2012 Sep; 28(3):895-902. PubMed ID: 22751949
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells.
Ko JC; Chiu HC; Syu JJ; Jian YJ; Chen CY; Jian YT; Huang YJ; Wo TY; Lin YW
Biochem Pharmacol; 2014 Mar; 88(1):119-27. PubMed ID: 24447935
[TBL] [Abstract][Full Text] [Related]
15. Thymidine phosphorylase gene transfer inhibits vascular smooth muscle cell proliferation by upregulating heme oxygenase-1 and p27KIP1.
Li W; Tanaka K; Morioka K; Uesaka T; Yamada N; Takamori A; Handa M; Tanabe S; Ihaya A
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1370-5. PubMed ID: 15879300
[TBL] [Abstract][Full Text] [Related]
16. Thymidine phosphorylase induces angiogenesis in vivo and in vitro: an evaluation of possible mechanisms.
Sengupta S; Sellers LA; Matheson HB; Fan TP
Br J Pharmacol; 2003 May; 139(2):219-31. PubMed ID: 12770927
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of thymidine phosphorylase expression by using an HSP90 inhibitor potentiates the cytotoxic effect of cisplatin in non-small-cell lung cancer cells.
Weng SH; Tseng SC; Huang YC; Chen HJ; Lin YW
Biochem Pharmacol; 2012 Jul; 84(1):126-36. PubMed ID: 22480737
[TBL] [Abstract][Full Text] [Related]
18. Thymidine phosphorylase activity in nonsmall cell lung carcinoma tissues.
Yano T; Takeo S
Cancer; 2001 Nov; 92(10):2658-61. PubMed ID: 11745201
[TBL] [Abstract][Full Text] [Related]
19. Role of thymidine phosphorylase on invasiveness and metastasis in lung adenocarcinoma.
Sato J; Sata M; Nakamura H; Inoue S; Wada T; Takabatake N; Otake K; Tomoike H; Kubota I
Int J Cancer; 2003 Oct; 106(6):863-70. PubMed ID: 12918063
[TBL] [Abstract][Full Text] [Related]
20. Keap1-Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P Protein.
Chien MH; Lee WJ; Hsieh FK; Li CF; Cheng TY; Wang MY; Chen JS; Chow JM; Jan YH; Hsiao M; Hua KT; Kuo ML
Clin Cancer Res; 2015 Oct; 21(20):4719-32. PubMed ID: 26078391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
